Corporate Philanthropy - Best Practices at Novartis AG


IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
  
Case Studies | Case Study in Business, Management, Operations, Strategy, Case Study

ICMR HOME | Case Studies Collection

To download Corporate Philanthropy - Best Practices at Novartis AG case study (Case Code: BECG063) click on the button below, and select the case from the list of available cases:



» Business Ethics Case Studies
» Case Studies Collection
» ICMR Home
» Business Ethics Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company

Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.

Case Details:

Price:
Case Code : BECG063 For delivery in electronic format: Rs. 500 ;
For delivery through courier (within India): Rs. 500 + Rs. 25 for Shipping & Handling Charges

Themes

Corporate Philanthropy, Corporate Citizenship, Social Responsibility
Case Length : 23 Pages
Period : 2000-06
Organization : Novartis AG, Novartis Foundation for Sustainable
Pub Date : 2006
Teaching Note : Available
Countries : Switzerland
Industry : Pharmaceutical

Abstract:

The case discusses the corporate philanthropy initiatives of Switzerland based pharma major Novartis AG. Even before Novartis was incorporated in 1996, through the merger of Ciba Geigy and Sandoz; Ciba Geigy was actively involved in philanthropic activities and had set up a foundation in 1979, which went on to become Novartis Foundation after the merger. Novartis also adopted the UN Global Compact principles in the year 2000. Novartis and Novartis Foundation were actively involved in several philanthropic projects to help the poor in underdeveloped countries. The case discusses in detail few such projects like anti-leprosy program, initiatives to eliminate malaria and tuberculosis (TB), and programs for AIDS orphans etc.

The company also started a research institute to carryout research on tropical diseases. The institute was actively involved in finding cure for dengue fever and TB. The philanthropic activities of Novartis were extended to include poor people of the developed countries, and the company started providing its highly effective cancer drug Gleevec in the US free of cost for patients whose income was low.

Issues:

» Study and analyze the importance of philanthropy initiatives by organizations

» Determine the rationale for corporate philanthropic activities and how to make them sustainable

» Evaluate how corporates can play their part in the development of the society

» Understand the principles of the UN Global Compact and its implementation by Novartis

Contents:

  Page No.
Introduction 1
Background Note 2
About Novartis Foundation 3
Novartis Corporate Citizenship Initiative 4
Tackling Leprosy 6
Fighting Against Tuberculosis 9
Roll Back Malaria Initiative 11
AIDS Orphans 11
Novartis Institute for Tropical Diseases 11
Other Innovative Initiatives 13
The Benefits and Challenges 13
Exhibits 15

Keywords:

Novartis AG, Novartis Foundation for Sustainable Development, Corporate Philanthropy, Social Responsibility , Sustainability Management, UN Global Compact, Access to Medicines Program, Novartis Code of Conduct, Social Marketing, Corporate Citizenship

Corporate Philanthropy - Best Practices at Novartis AG - Next Page>>

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.